Groundbreaking study reveals most effective adjunctive drug for Parkinson’s disease Post author: Post published:October 23, 2023 Post category:uncategorized The efficacy, tolerability, and safety of various anti-Parkinson’s drugs. You Might Also Like Genetic analysis challenges the idea that loneliness directly causes diseases September 17, 2024 Clinical trial finds pomalidomide effective for treating rare bleeding disorder September 18, 2024 Tumor immune cell patterns predict melanoma immunotherapy response April 22, 2026